In fact, several inflammatory markers, such as C-reactive protein (CRP), IL-6, monocyte chemotactic protein 1 (MCP-1), and TNF-α, have been found to be elevated in patients with NAFLD and even more exacerbated in patients with NASH compared to healthy controls, independent of obesity and other confounding factors. The gene discussed is CCL2; the disease is metabolic dysfunction-associated steatotic liver disease.